Literature DB >> 18984605

Resistance training in patients with single, large-scale deletions of mitochondrial DNA.

Julie L Murphy1, Emma L Blakely, Andrew M Schaefer, Langping He, Phil Wyrick, Ronald G Haller, Robert W Taylor, Douglass M Turnbull, Tanja Taivassalo.   

Abstract

Dramatic tissue variation in mitochondrial heteroplasmy has been found to exist in patients with sporadic mitochondrial DNA (mtDNA) mutations. Despite high abundance in mature skeletal muscle, levels of the causative mutation are low or undetectable in satellite cells. The activation of these typically quiescent mitotic cells and subsequent shifting of wild-type mtDNA templates to mature muscle have been proposed as a means of restoring a more normal mitochondrial genotype and function in these patients. Because resistance exercise is known to serve as a stimulus for satellite cell induction within active skeletal muscle, this study sought to assess the therapeutic potential of resistance training in eight patients with single, large-scale mtDNA deletions by assessing: physiological determinants of peak muscle strength and oxidative capacity and muscle biopsy-derived measures of damage, mtDNA mutation load, level of oxidative impairment and satellite cell numbers. Our results show that 12 weeks of progressive overload leg resistance training led to: (i) increased muscle strength; (ii) myofibre damage and regeneration; (iii) increased proportion of neural cell adhesion molecule (NCAM)-positive satellite cells; (iv) improved muscle oxidative capacity. Taken together, we believe these findings support the hypothesis of resistance exercise-induced mitochondrial gene-shifting in muscle containing satellite cells which have low or absent levels of deleted mtDNA. Further investigation is warranted to refine parameters of the exercise training protocol in order to maximize the training effect on mitochondrial genotype and treatment potential for patients with selected, sporadic mutations of mtDNA in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984605     DOI: 10.1093/brain/awn252

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  63 in total

Review 1.  Altering the balance between healthy and mutated mitochondrial DNA.

Authors:  Paul M Smith; Robert N Lightowlers
Journal:  J Inherit Metab Dis       Date:  2010-05-27       Impact factor: 4.982

Review 2.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

Review 3.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 4.  Nutrition and exercise in Pompe disease.

Authors:  Mark A Tarnopolsky; Mats I Nilsson
Journal:  Ann Transl Med       Date:  2019-07

Review 5.  Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.

Authors:  Susana Peralta; Alessandra Torraco; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

Review 6.  Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress.

Authors:  Hagir B Suliman; Claude A Piantadosi
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

8.  OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules.

Authors:  Patrick Yu-Wai-Man; Kamil S Sitarz; David C Samuels; Philip G Griffiths; Amy K Reeve; Laurence A Bindoff; Rita Horvath; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2010-05-18       Impact factor: 6.150

Review 9.  The elusive magic pill: finding effective therapies for mitochondrial disorders.

Authors:  Amy Goldstein; Lynne A Wolfe
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 10.  The mitochondrial brain: From mitochondrial genome to neurodegeneration.

Authors:  Helen E Turnbull; Nichola Z Lax; Daria Diodato; Olaf Ansorge; Doug M Turnbull
Journal:  Biochim Biophys Acta       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.